Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge

INTRODUCTION: Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC) patients predicts response to EGFR tyrosine kinase inhibitors (TKIs). The Idylla™ system (Biocartis, Mechelen, Belgium) is a fully integrated, ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Turkmani, M. Rabie, Suriawinata, Michael A., Deharvengt, Sophie J., Green, Donald C., Black, Candice C., Shirai, Keisuke, Dragnev, Konstantin H., Tsongalis, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062922/
https://www.ncbi.nlm.nih.gov/pubmed/32181314
http://dx.doi.org/10.1016/j.plabm.2020.e00156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062922/
https://www.ncbi.nlm.nih.gov/pubmed/32181314
http://dx.doi.org/10.1016/j.plabm.2020.e00156

Ejemplares similares